Quantcast

Empire State Today

Sunday, November 24, 2024

New York: Biologics companies were the second most FDA inspected companies in New York in Q3 2023

Webp qjor7q6aba3j2gn1lh89sh3yxtfn

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

In the third quarter of 2023, 11 Biologics companies received 11 FDA inspections in New York, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in New York, equalling 9.2% of all inspections in the third quarter of 2023.

Of all the New York companies involved in the Biologics sector, New York Blood Center Enterprises received the most citations from the FDA in the third quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in New York During Q3 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring9----
Blood and Blood Products82--
Compliance: Devices37--
Drug Quality Assurance221
Food Composition, Standards, Labeling and Econ43--
Foodborne Biological Hazards4722--
Human Cellular, Tissue, and Gene Therapies42--
Monitoring of Marketed Animal Drugs, Feed, and Devices26--
Postmarket Assurance: Devices81--
Technical Assistance: Food and Cosmetics6----

MORE NEWS